MedTrace Logo

Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.

NCT01890291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162

Last updated 2023-06-26

No results posted yet for this study

Summary

To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular carcinoma in Korea

Conditions

Sponsors & Collaborators

  • GC Cell Corporation

    lead INDUSTRY

Principal Investigators

  • Jung Hwan Yoon, MD · Seoul National University Hospital

  • Joon Hyeok Lee, MD · Samsung Medical Center

  • Young-Suk Lim, MD · Asan Medical Center

  • Tae Gin Song, MD · Korea University Ansan Hospital

  • Jong Eun Yeon, MD · Korea University Guro Hospital

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-01-31
Completion
2016-02-29

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01890291 on ClinicalTrials.gov